Drug Type Biosimilar, Monoclonal antibody |
Synonyms Ibalizumab-UIYK Biosimilar (Microbio Co., Ltd.) |
Action inhibitors |
Mechanism CD4 inhibitors(T-cell surface antigen CD4 inhibitors), Viral fusion proteins inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acquired Immunodeficiency Syndrome | Discovery | Taiwan Province | 30 Aug 2022 |